Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
vNOTES_NMBDIET
NCT07730970Recruiting
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of rocuronium in benign gynecological disease (4 arms), sponsored by Fatih Sultan Mehmet Training and Research Hospital. Primary endpoint: Lowest CO2 insufflation pressure at which the surgical field is adequate (vNOTES-OVI >= 1). Started Jul 2026; status: recruiting.
02
Drugs
rocuronium
03
Conditions
benign gynecological disease
Beyond the preview
Go deeper on NCT07730970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730970.